PRNewswire - Techseriesinsight

May 30, 2025
PRNewswire
Biotechnology

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it...

May 30, 2025
PRNewswire
Biotechnology

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and...

May 30, 2025
PRNewswire
Data Management Platform

Milvus Hits 35,000 GitHub Stars as AI Developers Embrace Open-Source Vector Database

Zilliz, creator of the leading open-source vector database Milvus, today announced that Milvus has achieved 35,000 stars on GitHub, establishing it as the most popular vector database platform globally. The...

May 30, 2025
PRNewswire
Cloud

Infosys BPM Unveils AI Agents to Revolutionize Finance and Accounting Services

Infosys BPM, the business process management arm of Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), today announced the launch of AI agents for invoice processing within its flagship Infosys Accounts Payable on Cloud solution....

May 30, 2025
PRNewswire
Blockchain Technology

Alchemy Pay Integrates USD1 On-Ramp, Expanding Stablecoin Access with World Liberty Financial

Alchemy Pay, the world-leading fiat-crypto payment gateway, has announced a strategic integration with decentralized finance platform World Liberty Financial Inc. (WLFI) to support seamless on-ramp access to USD1, WLFI’s US dollar stablecoin. WLFI, the...

May 29, 2025
PRNewswire
Healthcare

Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence

On May 20, Medicilon Preclinical Research (Shanghai) LLC (“Medicilon”) announces that it has successfully passed an on-site inspection by the FDA. The company receives an official Establishment Inspection Report (EIR)...

May 29, 2025
PRNewswire
Healthcare

A joint study by Duchesnay and PeriPharm exposes critical gaps in access to innovative women’s health products in Canada

Duchesnay, member of Duchesnay Pharmaceutical Group (DPG), winner of the 2024 Life Sciences Innovation Award by ADRIQ, in collaboration with PeriPharm, is proud to announce the results of a...

May 29, 2025
PRNewswire
Biotechnology

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson’s Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Ltd. (NYSE: BHVN) (“Biohaven”), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies to treat a broad range of rare and common diseases,...

May 29, 2025
PRNewswire
Biotechnology

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering

Immunic, Inc. (“Immunic” or the “Company”) (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced the pricing...

May 29, 2025
PRNewswire
Data Management Platform

Brainomix Driving Treatment Decisions in Stroke: New Studies Presented at Leading European Stroke Conference

Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, presented a series of new studies at the European Stroke Organisation Conference (ESOC) in Helsinki, solidifying the position...